AIM ImmunoTech, Inc. (AIM)

1.05 -0.07 (-6.25%) USD  |  NYAM  |  Feb 20, 16:00
1.05 0.00 (0.00%) Pre-Market: 20:00
More

AIM ImmunoTech Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
Agenus, Inc. Upgrade
Curis, Inc. Upgrade
LadRx Corp. --
Plus Therapeutics, Inc. Upgrade

Return on Net Operating Assets Related Metrics

Return on Assets Upgrade
Profit Margin (Quarterly) Upgrade
Gross Profit Margin (Quarterly) Upgrade
Operating Margin (Quarterly) Upgrade